Invention Grant
- Patent Title: Heterocyclic compounds as anti-viral agents
-
Application No.: US17503626Application Date: 2021-10-18
-
Publication No.: US11945824B2Publication Date: 2024-04-02
- Inventor: Yat Sun Or , Yong He , Kevin McGrath , Ruichao Shen , Adam Szymaniak , Xuechao Xing , In Jong Kim , Guoqiang Wang
- Applicant: ENANTA PHARMACEUTICALS, INC.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: A61K31/706
- IPC: A61K31/706 ; A61K31/635 ; A61K45/06 ; A61P31/14 ; A61P35/00 ; C07D491/048
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:
which inhibit Respiratory Syncytial Virus (RSV) or HMPV. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV or HMPV infection. The invention also relates to methods of treating an RSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
which inhibit Respiratory Syncytial Virus (RSV) or HMPV. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV or HMPV infection. The invention also relates to methods of treating an RSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20220119398A1 HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS Public/Granted day:2022-04-21
Information query
